Search
Labcorp Holdings Inc
LHAdd to Watchlist
326.890USD
-4.610-1.39%
Close 09-04 16:00（ET）
26.44BMarket Cap
28.75P/E TTM
Forecast
Currency: USD Updated: 2026-09-04The current earnings forecast score of Labcorp Holdings Inc is 8.30, ranking 19 out of 74 in the Healthcare Providers & Services industry. The average price target is 304.00, with a high of 342.00 and a low of 260.00.
Analyst Rating
Based on
19
analysts
Buy
Current Rating
340.377
Target Price
+2.68%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
59
Total
9
Median
9
Average
Company name
Ratings
Analysts
Labcorp Holdings Inc
LH
19
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
26
Teladoc Health Inc
TDOC
25
Natera Inc
NTRA
24
Tenet Healthcare Corp
THC
23
1
2
3
...
12
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Labcorp Holdings Inc's expected revenue for the next quarter?
Labcorp Holdings Inc's expected revenue is 3.76B.
What is Labcorp Holdings Inc's price target?
Analysts forecast that Labcorp Holdings Inc's price target is USD 304.00, with the highest forecast at USD 342.00 and the lowest forecast at USD 260.00.
How have Labcorp Holdings IncLH's recent earnings per share performed?
The market expectation was USD 3.66, while Labcorp Holdings IncLH's earnings per share (EPS) for the previous quarter was USD 3.38. EPS for the next quarter is expected at USD 4.66.
What is the analyst rating for Labcorp Holdings Inc?
Based on the ratings of Labcorp Holdings Inc's stock from 19 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.